{"transactions":[{"id":4618379,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-09-15T21:04:05.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2419,"price":156.22,"value":377896.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of PRSUs. No shares were sold."}],"balance_after":18289,"source":{"system":"sec-edgar","filing":"0001965808-26-000015","document":"wk-form4_1789506243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1965808/000196580826000015/wk-form4_1789506243.xml","form_type":"4"}},{"id":4618378,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-09-15T21:04:05.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":4483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026."}],"balance_after":20708,"source":{"system":"sec-edgar","filing":"0001965808-26-000015","document":"wk-form4_1789506243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1965808/000196580826000015/wk-form4_1789506243.xml","form_type":"4"}},{"id":710857,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2026-07-13T20:27:43.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":false,"shares":4367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted February 1, 2021 and vested at 25% upon first anniversary (February 1, 2022) and remaining 75% vested in 36 equal monthly installments beginning on March 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":106.02,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":4367},"source":{"system":"sec-edgar","filing":"0001965808-26-000013","document":"wk-form4_1783974461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000013/wk-form4_1783974461.xml","form_type":"4"}},{"id":710856,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:27:43.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":4367,"price":181.02,"value":790514.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":16225,"source":{"system":"sec-edgar","filing":"0001965808-26-000013","document":"wk-form4_1783974461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000013/wk-form4_1783974461.xml","form_type":"4"}},{"id":710855,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:27:43.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":true,"shares":4367,"price":106.02,"value":462989.34,"ownership":{"direct":true},"balance_after":20592,"source":{"system":"sec-edgar","filing":"0001965808-26-000013","document":"wk-form4_1783974461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000013/wk-form4_1783974461.xml","form_type":"4"}},{"id":712187,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":8433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted February 13, 2023 and vests in 48 equal monthly installments beginning March 13, 2023."}],"balance_after":7478,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":8433},"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712186,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-08","kind":"exercise","planned":true,"acquired":false,"shares":2737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted February 13, 2023 and vests in 48 equal monthly installments beginning March 13, 2023."}],"balance_after":15911,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":2737},"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712185,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":3401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted February 13, 2023 and vests in 48 equal monthly installments beginning March 13, 2023."}],"balance_after":18648,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":3401},"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712184,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":8433,"price":178.7187,"value":1507134.7971,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $178.52 to $179.19. The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16225,"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712183,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":8433,"price":103.52,"value":872984.16,"ownership":{"direct":true},"balance_after":24658,"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712182,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-08","kind":"sale","planned":true,"acquired":false,"shares":2737,"price":178.543,"value":488672.191,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $178.52 to $178.59. The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16225,"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712181,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-08","kind":"exercise","planned":true,"acquired":true,"shares":2737,"price":103.52,"value":283334.24,"ownership":{"direct":true},"balance_after":18962,"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712180,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":3401,"price":178.5666,"value":607305.0066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $178.52 to $178.75. The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16225,"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":712179,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-07-09T22:41:02.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":3401,"price":103.52,"value":352071.52,"ownership":{"direct":true},"balance_after":19626,"source":{"system":"sec-edgar","filing":"0001965808-26-000011","document":"wk-form4_1783636859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000011/wk-form4_1783636859.xml","form_type":"4"}},{"id":755916,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2026-06-02T22:03:14.000Z","date":"2026-05-29","kind":"exercise","planned":true,"acquired":false,"shares":2261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022."}],"balance_after":0,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":2261},"source":{"system":"sec-edgar","filing":"0001965808-26-000007","document":"wk-form4_1780437791.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000007/wk-form4_1780437791.xml","form_type":"4"}},{"id":755915,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-06-02T22:03:14.000Z","date":"2026-05-29","kind":"sale","planned":true,"acquired":false,"shares":2261,"price":156.71,"value":354321.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":16225,"source":{"system":"sec-edgar","filing":"0001965808-26-000007","document":"wk-form4_1780437791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000007/wk-form4_1780437791.xml","form_type":"4"}},{"id":755914,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-06-02T22:03:14.000Z","date":"2026-05-29","kind":"exercise","planned":true,"acquired":true,"shares":2261,"price":79.02,"value":178664.22,"ownership":{"direct":true},"balance_after":18486,"source":{"system":"sec-edgar","filing":"0001965808-26-000007","document":"wk-form4_1780437791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000007/wk-form4_1780437791.xml","form_type":"4"}},{"id":902251,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":5479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030."}],"balance_after":5479,"derivative":{"underlying":"Common Stock","underlying_shares":5479},"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902250,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":31234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":31234,"derivative":{"exercise_price":124.12,"expiration_date":"2036-02-13","underlying":"Common Stock","underlying_shares":31234},"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902249,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,358 shares on February 13, 2024, vested as to 1,358 shares on February 13, 2025, vested as to 1,359 shares on February 13, 2026, and will vest as to 1,359 shares on February 13, 2027, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,358 shares on February 13, 2024, vested as to 1,358 shares on February 13, 2025, vested as to 1,359 shares on February 13, 2026, and will vest as to 1,359 shares on February 13, 2027, subject to the terms and conditions of the award."}],"balance_after":1359,"derivative":{"underlying":"Common Stock","underlying_shares":1359},"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902248,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, vested as to 1,401 shares on February 13, 2026, and will vest as to 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, vested as to 1,401 shares on February 13, 2026, and will vest as to 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."}],"balance_after":2802,"derivative":{"underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902247,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU was granted to the Reporting Person on February 12, 2025. In accordance with the terms of the RSU, the award vested as to 1,600 shares on February 12, 2026, and will vest as to 1,600 shares on February 12, 2027, 1,600 shares on February 12, 2028, and 1,601 shares on February 12, 2029, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU was granted to the Reporting Person on February 12, 2025. In accordance with the terms of the RSU, the award vested as to 1,600 shares on February 12, 2026, and will vest as to 1,600 shares on February 12, 2027, 1,600 shares on February 12, 2028, and 1,601 shares on February 12, 2029, subject to the terms and conditions of the award."}],"balance_after":4801,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902246,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":10755,"price":124.12,"value":1334910.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":16225,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902245,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":19935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On May 19, 2023, the Reporting Person was granted PRSUs representing the right to receive shares of the Issuer's common stock based upon the achievement of specified performance metrics over the three-year performance period ending on December 31, 2025. Effective February 13, 2026, the achievement of the applicable performance metrics and the resulting payout level were certified, and, as a result of such certification, the PRSUs vested at 125% of the target number of shares subject to the award."}],"balance_after":26980,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902244,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":734,"price":124.12,"value":91104.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":7045,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902243,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1359,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7779,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902242,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":756,"price":124.12,"value":93834.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":6420,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902241,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7176,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902240,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":881,"price":123.1,"value":108451.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\") or performance restricted stock units (\"PRSUs\"), as applicable. No shares were sold."}],"balance_after":5775,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":902239,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:45:01.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6656,"source":{"system":"sec-edgar","filing":"0001965808-26-000005","document":"wk-form4_1771368298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000005/wk-form4_1771368298.xml","form_type":"4"}},{"id":922920,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restriced Stock Unit","published_at":"2026-02-03T23:04:51.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 800 shares on January 31, 2023, vested as to 800 shares on January 31, 2024, vested as to 801 shares on January 31, 2025, and vested as to 801 shares on January 31, 2026, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 800 shares on January 31, 2023, vested as to 800 shares on January 31, 2024, vested as to 801 shares on January 31, 2025, and vested as to 801 shares on January 31, 2026, subject to the terms and conditions of the award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":801},"source":{"system":"sec-edgar","filing":"0001965808-26-000003","document":"wk-form4_1770159888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000003/wk-form4_1770159888.xml","form_type":"4"}},{"id":922919,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:04:51.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":475,"price":136.06,"value":64628.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\"). No shares were sold."}],"balance_after":5056,"source":{"system":"sec-edgar","filing":"0001965808-26-000003","document":"wk-form4_1770159888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000003/wk-form4_1770159888.xml","form_type":"4"}},{"id":922918,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:04:51.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5531,"source":{"system":"sec-edgar","filing":"0001965808-26-000003","document":"wk-form4_1770159888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000196580826000003/wk-form4_1770159888.xml","form_type":"4"}},{"id":1088949,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2025-07-11T21:15:12.000Z","date":"2025-07-10","kind":"exercise","planned":true,"acquired":false,"shares":457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":2261,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":457},"source":{"system":"sec-edgar","filing":"0000914475-25-000153","document":"wk-form4_1752268504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000153/wk-form4_1752268504.xml","form_type":"4"}},{"id":1088948,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-07-11T21:15:12.000Z","date":"2025-07-10","kind":"sale","planned":true,"acquired":false,"shares":457,"price":135,"value":61695.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":4730,"source":{"system":"sec-edgar","filing":"0000914475-25-000153","document":"wk-form4_1752268504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000153/wk-form4_1752268504.xml","form_type":"4"}},{"id":1088947,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-07-11T21:15:12.000Z","date":"2025-07-10","kind":"exercise","planned":true,"acquired":true,"shares":457,"price":79.02,"value":36112.14,"ownership":{"direct":true},"balance_after":5187,"source":{"system":"sec-edgar","filing":"0000914475-25-000153","document":"wk-form4_1752268504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000153/wk-form4_1752268504.xml","form_type":"4"}},{"id":1268302,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, and will vest as to 1,401 shares on February 13, 2026, 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"This RSU was granted to the Reporting Person on February 13, 2024.  In accordance with the terms of the RSU, the award vested as to 1,401 shares on February 13, 2025, and will vest as to 1,401 shares on February 13, 2026, 1,401 shares on February 13, 2027, and 1,401 shares on February 13, 2028, subject to the terms and conditions of the award."}],"balance_after":4203,"derivative":{"underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268301,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":1358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,358 shares on February 13, 2024, vested as to 1,358 shares on February 13, 2025, and will vest as to 1,359 shares on February 13, 2026, and 1,359 shares on February 13, 2027, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This RSU was granted to the Reporting Person on February 13, 2023.  In accordance with the terms of the RSU, the award vested as to 1,358 shares on February 13, 2024, vested as to 1,358 shares on February 13, 2025, and will vest as to 1,359 shares on February 13, 2026, and 1,359 shares on February 13, 2027, subject to the terms and conditions of the award."}],"balance_after":2718,"derivative":{"underlying":"Common Stock","underlying_shares":1358},"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268300,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-12","kind":"grant","planned":true,"acquired":true,"shares":6401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 12, 2026, February 12, 2027, February 12, 2028, and February 12, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 12, 2026, February 12, 2027, February 12, 2028, and February 12, 2029."}],"balance_after":6401,"derivative":{"underlying":"Common Stock","underlying_shares":6401},"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268299,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-12","kind":"grant","planned":true,"acquired":true,"shares":34153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 12, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":34153,"derivative":{"exercise_price":117.18,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":34153},"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268298,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":755,"price":116.7214,"value":88124.657,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.98 to $117.75. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4730,"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268297,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5485,"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268296,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":716,"price":116.6892,"value":83549.4672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.98 to $117.35. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4084,"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1268295,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-14T23:13:58.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":1358,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4800,"source":{"system":"sec-edgar","filing":"0000914475-25-000061","document":"wk-form4_1739574830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000061/wk-form4_1739574830.xml","form_type":"4"}},{"id":1285983,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-04T22:45:18.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":false,"shares":1179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 1, 2021.  In accordance with the terms of the RSU, the award vested as to 1,180 shares on February 1, 2022, vested as to 1,179 shares on February 1, 2023, vested as to 1,179 shares on February 1, 2024, and vested as to 1,179 shares on February 1, 2025, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This RSU was granted to the Reporting Person on February 1, 2021.  In accordance with the terms of the RSU, the award vested as to 1,180 shares on February 1, 2022, vested as to 1,179 shares on February 1, 2023, vested as to 1,179 shares on February 1, 2024, and vested as to 1,179 shares on February 1, 2025, subject to the terms and conditions of the award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1179},"source":{"system":"sec-edgar","filing":"0000914475-25-000024","document":"wk-form4_1738709111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000024/wk-form4_1738709111.xml","form_type":"4"}},{"id":1285982,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restriced Stock Unit","published_at":"2025-02-04T22:45:18.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 800 shares on January 31, 2023, vested as to 800 shares on January 31, 2024, vested as to 801 shares on January 31, 2025, and will vest as to 801 shares on January 31, 2026, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 800 shares on January 31, 2023, vested as to 800 shares on January 31, 2024, vested as to 801 shares on January 31, 2025, and will vest as to 801 shares on January 31, 2026, subject to the terms and conditions of the award."}],"balance_after":801,"derivative":{"underlying":"Common Stock","underlying_shares":801},"source":{"system":"sec-edgar","filing":"0000914475-25-000024","document":"wk-form4_1738709111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000024/wk-form4_1738709111.xml","form_type":"4"}},{"id":1285981,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:45:18.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":623,"price":149.29,"value":93007.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":3442,"source":{"system":"sec-edgar","filing":"0000914475-25-000024","document":"wk-form4_1738709111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000024/wk-form4_1738709111.xml","form_type":"4"}},{"id":1285980,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:45:18.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":true,"shares":1179,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4065,"source":{"system":"sec-edgar","filing":"0000914475-25-000024","document":"wk-form4_1738709111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000024/wk-form4_1738709111.xml","form_type":"4"}},{"id":1285979,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:45:18.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":422,"price":153.0491,"value":64586.7202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.91 to $154.35. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2886,"source":{"system":"sec-edgar","filing":"0000914475-25-000024","document":"wk-form4_1738709111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000024/wk-form4_1738709111.xml","form_type":"4"}},{"id":1285978,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:45:18.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3308,"source":{"system":"sec-edgar","filing":"0000914475-25-000024","document":"wk-form4_1738709111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000024/wk-form4_1738709111.xml","form_type":"4"}},{"id":1316806,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2025-01-03T21:23:48.000Z","date":"2024-12-31","kind":"exercise","planned":true,"acquired":false,"shares":272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":2718,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":272},"source":{"system":"sec-edgar","filing":"0000914475-25-000002","document":"wk-form4_1735939418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000002/wk-form4_1735939418.xml","form_type":"4"}},{"id":1316805,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-01-03T21:23:48.000Z","date":"2024-12-31","kind":"sale","planned":true,"acquired":false,"shares":272,"price":138.1,"value":37563.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":2507,"source":{"system":"sec-edgar","filing":"0000914475-25-000002","document":"wk-form4_1735939418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000002/wk-form4_1735939418.xml","form_type":"4"}},{"id":1316804,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2025-01-03T21:23:48.000Z","date":"2024-12-31","kind":"exercise","planned":true,"acquired":true,"shares":272,"price":79.02,"value":21493.44,"ownership":{"direct":true},"balance_after":2779,"source":{"system":"sec-edgar","filing":"0000914475-25-000002","document":"wk-form4_1735939418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000002/wk-form4_1735939418.xml","form_type":"4"}},{"id":1325812,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-12-19T21:37:41.000Z","date":"2024-12-17","kind":"exercise","planned":true,"acquired":false,"shares":1091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":2990,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":1091},"source":{"system":"sec-edgar","filing":"0000914475-24-000224","document":"wk-form4_1734644255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000224/wk-form4_1734644255.xml","form_type":"4"}},{"id":1325811,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-12-19T21:37:41.000Z","date":"2024-12-17","kind":"sale","planned":true,"acquired":false,"shares":1091,"price":135,"value":147285.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":2507,"source":{"system":"sec-edgar","filing":"0000914475-24-000224","document":"wk-form4_1734644255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000224/wk-form4_1734644255.xml","form_type":"4"}},{"id":1325810,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-12-19T21:37:41.000Z","date":"2024-12-17","kind":"exercise","planned":true,"acquired":true,"shares":1091,"price":79.02,"value":86210.82,"ownership":{"direct":true},"balance_after":3598,"source":{"system":"sec-edgar","filing":"0000914475-24-000224","document":"wk-form4_1734644255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000224/wk-form4_1734644255.xml","form_type":"4"}},{"id":1432943,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-08-15T21:06:01.000Z","date":"2024-08-13","kind":"exercise","planned":true,"acquired":false,"shares":3043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":22049,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":3043},"source":{"system":"sec-edgar","filing":"0000914475-24-000191","document":"wk-form4_1723755955.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000191/wk-form4_1723755955.xml","form_type":"4"}},{"id":1432942,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-08-15T21:06:01.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":4100,"price":150.0813,"value":615333.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.28. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2507,"source":{"system":"sec-edgar","filing":"0000914475-24-000191","document":"wk-form4_1723755955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000191/wk-form4_1723755955.xml","form_type":"4"}},{"id":1432941,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-08-15T21:06:01.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":3043,"price":150.1305,"value":456847.1115,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.44. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":6607,"source":{"system":"sec-edgar","filing":"0000914475-24-000191","document":"wk-form4_1723755955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000191/wk-form4_1723755955.xml","form_type":"4"}},{"id":1432940,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-08-15T21:06:01.000Z","date":"2024-08-13","kind":"exercise","planned":true,"acquired":true,"shares":3043,"price":103.52,"value":315011.36,"ownership":{"direct":true},"balance_after":9650,"source":{"system":"sec-edgar","filing":"0000914475-24-000191","document":"wk-form4_1723755955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000191/wk-form4_1723755955.xml","form_type":"4"}},{"id":1438130,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-08-08T21:16:58.000Z","date":"2024-08-06","kind":"exercise","planned":true,"acquired":false,"shares":273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":4081,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":273},"source":{"system":"sec-edgar","filing":"0000914475-24-000189","document":"wk-form4_1723151810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000189/wk-form4_1723151810.xml","form_type":"4"}},{"id":1438129,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-08-08T21:16:58.000Z","date":"2024-08-06","kind":"sale","planned":true,"acquired":false,"shares":273,"price":147.7,"value":40322.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":6607,"source":{"system":"sec-edgar","filing":"0000914475-24-000189","document":"wk-form4_1723151810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000189/wk-form4_1723151810.xml","form_type":"4"}},{"id":1438128,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-08-08T21:16:58.000Z","date":"2024-08-06","kind":"exercise","planned":true,"acquired":true,"shares":273,"price":79.02,"value":21572.46,"ownership":{"direct":true},"balance_after":6880,"source":{"system":"sec-edgar","filing":"0000914475-24-000189","document":"wk-form4_1723151810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000189/wk-form4_1723151810.xml","form_type":"4"}},{"id":1452087,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":false,"shares":1557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":25092,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":1557},"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1452086,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":26649,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1452085,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":900,"price":150.04,"value":135036.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":6607,"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1452084,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":1557,"price":150,"value":233550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023"}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1452083,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":true,"shares":1557,"price":103.52,"value":161180.64,"ownership":{"direct":true},"balance_after":9064,"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1452082,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":400,"price":150.1025,"value":60041.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.05 to $150.21. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1452081,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-18T21:00:01.000Z","date":"2024-07-16","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":103.52,"value":41408.0,"ownership":{"direct":true},"balance_after":7907,"source":{"system":"sec-edgar","filing":"0000914475-24-000174","document":"wk-form4_1721336394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000174/wk-form4_1721336394.xml","form_type":"4"}},{"id":1464240,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-07-03T01:09:40.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":4354,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":272},"source":{"system":"sec-edgar","filing":"0000914475-24-000164","document":"wk-form4_1719968973.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000164/wk-form4_1719968973.xml","form_type":"4"}},{"id":1464239,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-03T01:09:40.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":272,"price":138.11,"value":37565.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000164","document":"wk-form4_1719968973.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000164/wk-form4_1719968973.xml","form_type":"4"}},{"id":1464238,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-07-03T01:09:40.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":272,"price":79.02,"value":21493.44,"ownership":{"direct":true},"balance_after":7779,"source":{"system":"sec-edgar","filing":"0000914475-24-000164","document":"wk-form4_1719968973.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000164/wk-form4_1719968973.xml","form_type":"4"}},{"id":1493598,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-06-04T20:23:10.000Z","date":"2024-05-31","kind":"exercise","planned":true,"acquired":false,"shares":273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":4626,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":273},"source":{"system":"sec-edgar","filing":"0000914475-24-000162","document":"wk-form4_1717532582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000162/wk-form4_1717532582.xml","form_type":"4"}},{"id":1493597,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:23:10.000Z","date":"2024-05-31","kind":"sale","planned":true,"acquired":false,"shares":273,"price":136.55,"value":37278.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000162","document":"wk-form4_1717532582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000162/wk-form4_1717532582.xml","form_type":"4"}},{"id":1493596,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:23:10.000Z","date":"2024-05-31","kind":"exercise","planned":true,"acquired":true,"shares":273,"price":79.02,"value":21572.46,"ownership":{"direct":true},"balance_after":7780,"source":{"system":"sec-edgar","filing":"0000914475-24-000162","document":"wk-form4_1717532582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000162/wk-form4_1717532582.xml","form_type":"4"}},{"id":1523770,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-05-08T20:26:52.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":false,"shares":273,"price":79.02,"value":21572.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":4899,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":273},"source":{"system":"sec-edgar","filing":"0000914475-24-000119","document":"wk-form4_1715200000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000119/wk-form4_1715200000.xml","form_type":"4"}},{"id":1523769,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-05-08T20:26:52.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":273,"price":140.55,"value":38370.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000119","document":"wk-form4_1715200000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000119/wk-form4_1715200000.xml","form_type":"4"}},{"id":1523768,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-05-08T20:26:52.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":true,"shares":273,"price":79.02,"value":21572.46,"ownership":{"direct":true},"balance_after":7780,"source":{"system":"sec-edgar","filing":"0000914475-24-000119","document":"wk-form4_1715200000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000119/wk-form4_1715200000.xml","form_type":"4"}},{"id":1551302,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-04-03T20:44:07.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":272,"price":79.02,"value":21493.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":5172,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":272},"source":{"system":"sec-edgar","filing":"0000914475-24-000100","document":"wk-form4_1712177026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000100/wk-form4_1712177026.xml","form_type":"4"}},{"id":1551301,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-04-03T20:44:07.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":272,"price":137.3,"value":37345.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000100","document":"wk-form4_1712177026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000100/wk-form4_1712177026.xml","form_type":"4"}},{"id":1551300,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-04-03T20:44:07.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":272,"price":79.02,"value":21493.44,"ownership":{"direct":true},"balance_after":7779,"source":{"system":"sec-edgar","filing":"0000914475-24-000100","document":"wk-form4_1712177026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000100/wk-form4_1712177026.xml","form_type":"4"}},{"id":1562534,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-25T22:02:51.000Z","date":"2024-03-21","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":103.52,"value":517600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":27049,"derivative":{"exercise_price":103.52,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000914475-24-000098","document":"wk-form4_1711404161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000098/wk-form4_1711404161.xml","form_type":"4"}},{"id":1562533,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-25T22:02:51.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":145.064,"value":725320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Transactions at prices ranging from $145.00 to $145.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000098","document":"wk-form4_1711404161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000098/wk-form4_1711404161.xml","form_type":"4"}},{"id":1562532,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-25T22:02:51.000Z","date":"2024-03-21","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":103.52,"value":517600.0,"ownership":{"direct":true},"balance_after":12507,"source":{"system":"sec-edgar","filing":"0000914475-24-000098","document":"wk-form4_1711404161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000098/wk-form4_1711404161.xml","form_type":"4"}},{"id":1575522,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-15T21:15:30.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":106.02,"value":318060.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted February 1, 2021 and vests at 25% upon first anniversary (February 1, 2022) and remaining 75% vesting in 36 equal monthly installments beginning on March 1, 2022."}],"balance_after":4367,"derivative":{"exercise_price":106.02,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000914475-24-000090","document":"wk-form4_1710537319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000090/wk-form4_1710537319.xml","form_type":"4"}},{"id":1575521,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-15T21:15:30.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":140.1398,"value":420419.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.20.   The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000090","document":"wk-form4_1710537319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000090/wk-form4_1710537319.xml","form_type":"4"}},{"id":1575520,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-15T21:15:30.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":106.02,"value":318060.0,"ownership":{"direct":true},"balance_after":10507,"source":{"system":"sec-edgar","filing":"0000914475-24-000090","document":"wk-form4_1710537319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000090/wk-form4_1710537319.xml","form_type":"4"}},{"id":1582279,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-12T22:38:57.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":106.02,"value":21204.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted February 1, 2021 and vests at 25% upon first anniversary (February 1, 2022) and remaining 75% vesting in 36 equal monthly installments beginning on March 1, 2022."}],"balance_after":7367,"derivative":{"exercise_price":106.02,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0000914475-24-000086","document":"wk-form4_1710283129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000086/wk-form4_1710283129.xml","form_type":"4"}},{"id":1582278,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-12T22:38:57.000Z","date":"2024-03-08","kind":"exercise","planned":true,"acquired":false,"shares":1800,"price":106.02,"value":190836.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted February 1, 2021 and vests at 25% upon first anniversary (February 1, 2022) and remaining 75% vesting in 36 equal monthly installments beginning on March 1, 2022."}],"balance_after":7567,"derivative":{"exercise_price":106.02,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0000914475-24-000086","document":"wk-form4_1710283129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000086/wk-form4_1710283129.xml","form_type":"4"}},{"id":1582277,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-12T22:38:57.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":200,"price":140,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000086","document":"wk-form4_1710283129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000086/wk-form4_1710283129.xml","form_type":"4"}},{"id":1582276,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-12T22:38:57.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":true,"shares":200,"price":106.02,"value":21204.0,"ownership":{"direct":true},"balance_after":7707,"source":{"system":"sec-edgar","filing":"0000914475-24-000086","document":"wk-form4_1710283129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000086/wk-form4_1710283129.xml","form_type":"4"}},{"id":1582275,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-12T22:38:57.000Z","date":"2024-03-08","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":140.0292,"value":252052.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000086","document":"wk-form4_1710283129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000086/wk-form4_1710283129.xml","form_type":"4"}},{"id":1582274,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-12T22:38:57.000Z","date":"2024-03-08","kind":"exercise","planned":true,"acquired":true,"shares":1800,"price":106.02,"value":190836.0,"ownership":{"direct":true},"balance_after":9307,"source":{"system":"sec-edgar","filing":"0000914475-24-000086","document":"wk-form4_1710283129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000086/wk-form4_1710283129.xml","form_type":"4"}},{"id":1610902,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-01T00:02:10.000Z","date":"2024-02-29","kind":"exercise","planned":true,"acquired":false,"shares":273,"price":79.02,"value":21572.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":5444,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":273},"source":{"system":"sec-edgar","filing":"0000914475-24-000084","document":"wk-form4_1709251319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000084/wk-form4_1709251319.xml","form_type":"4"}},{"id":1610901,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-01T00:02:10.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":1544,"price":79.02,"value":122006.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":5717,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":1544},"source":{"system":"sec-edgar","filing":"0000914475-24-000084","document":"wk-form4_1709251319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000084/wk-form4_1709251319.xml","form_type":"4"}},{"id":1610900,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-01T00:02:10.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":79.02,"value":197550.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":7261,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000914475-24-000084","document":"wk-form4_1709251319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000084/wk-form4_1709251319.xml","form_type":"4"}},{"id":1610899,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-01T00:02:10.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":79.02,"value":197550.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022.  These options will expire ten years from the date of grant on January 31, 2032."}],"balance_after":9761,"derivative":{"exercise_price":79.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000914475-24-000084","document":"wk-form4_1709251319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000084/wk-form4_1709251319.xml","form_type":"4"}},{"id":1610898,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-01T00:02:10.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":273,"price":135.51,"value":36994.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":7507,"source":{"system":"sec-edgar","filing":"0000914475-24-000084","document":"wk-form4_1709251319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000084/wk-form4_1709251319.xml","form_type":"4"}},{"id":1610897,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":30877,"kind":"person","name":"Delaet Ingrid","position":1,"cik":"0001965808","reported_name":"Delaet Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2024-03-01T00:02:10.000Z","date":"2024-02-29","kind":"exercise","planned":true,"acquired":true,"shares":273,"price":79.02,"value":21572.46,"ownership":{"direct":true},"balance_after":7780,"source":{"system":"sec-edgar","filing":"0000914475-24-000084","document":"wk-form4_1709251319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000084/wk-form4_1709251319.xml","form_type":"4"}}],"next_cursor":"2024-03-01T00:02:10.000000Z,1610897"}